Contact

• workRoom A02 Applied Health Research
  University Park
  Nottingham
  NG7 2RD
  UK
• work0115 7487105
• Mickey.Lewis@nottingham.ac.uk
• NCTU

Biography

Mickey first started his research career as an Administrative Assistant in the Research and Development department of the Derby Hospital Foundation Trust in August 2010 which he then made the move to CSP Co-ordinator for the Trent CLRN in 2011.

In 2013 he became Site Setup Facilitator for the Nottingham Cancer Clinical Trials Team for NUH where he grew his experience in commercial and non-commercial costing, setting up and opening CTIMP trials. After working two years in oncology research Mickey became a Trial Co-ordinator for the Spinal Research Department for Nottingham University Hospitals NHS Trust managing the research department to assist with drafts, opening and running of the trials within the department.

In 2016, Mickey moved departments to work as a Trial Co-ordinator for the Hepatology and Gastroenterology research team (part of the Nottingham Digestive Disease Centre) where he worked with Hepatologists & Gastroenterologists to setup and run commercial trials. Mickey was involved with the setting up and running of several Gilead funded studies at Nottingham University Hospital NHS Trust that developed a groundbreaking successful treatment of Hepatitis C which is now used around the globe.

In September 2016 Mickey became a Trial Co-ordinator for Nottingham Clinical Trials Unit where up until the beginning of 2022 has been assisting trial managers with setup, running and close out of a wide range of trials including dermatology and neonatal but the majority of his focus has been on assisting in running the largest international UK led surgical oncology trial.

In 2018, Mickey was awarded the NUH Volunteer of the Year for his charity work to the hospital.

In April 2022, Mickey progressed to a Trial Manager where he currently works on running a BV study (DEVA study.ac.uk).

Recent Publications

• GOYAL, AMIT, MANN, G. BRUCE, FALLOWFIELD, LESLEY, DULEY, LELIA, REED, MALCOLM, DODWELL, DAVID, COLEMAN, ROBERT E., FAKIS, APOSTOLOS, NEWCOMBE, ROBERT, JENKINS, VALERIE, WHITHAM, DIANE, CHILDS, MARGARET, WHYNES, DAVID, KEELEY, VAUGHAN, ELLIS, IAN, FAIRBROTHER, PATRICIA, SADIQ, SHABINA, MONSON, KATHRYN, MONTGOMERY, ALAN, TAN, WEI, VALE, LUKE, HOMER, TARA, BADGER, HEATH, HAINES, RACHEL HELEN, LEWIS, MICKEY, MEGIAS, DANIEL, NABI, ZOHAL, SINGH, PREETINDER, CARAMAN, ANDREI and MILES, ELIZABETH, 2021. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes BMJ OPEN. 11(12),

• View all publications

• GOYAL, AMIT, MANN, G. BRUCE, FALLOWFIELD, LESLEY, DULEY, LELIA, REED, MALCOLM, DODWELL, DAVID, COLEMAN, ROBERT E., FAKIS, APOSTOLOS, NEWCOMBE, ROBERT, JENKINS, VALERIE, WHITHAM, DIANE, CHILDS, MARGARET, WHYNES, DAVID, KEELEY, VAUGHAN, ELLIS, IAN, FAIRBROTHER, PATRICIA, SADIQ, SHABINA, MONSON, KATHRYN, MONTGOMERY, ALAN, TAN, WEI, VALE, LUKE, HOMER, TARA, BADGER, HEATH, HAINES, RACHEL HELEN, LEWIS, MICKEY, MEGIAS, DANIEL, NABI, ZOHAL, SINGH, PREETINDER, CARAMAN, ANDREI and MILES, ELIZABETH, 2021. POSNOC-POsitive Sentinel NOde: adjuvant therapy alone versus adjuvant therapy plus Clearance or axillary radiotherapy: a randomised controlled trial of axillary treatment in women with early-stage breast cancer who have metastases in one or two sentinel nodes BMJ OPEN. 11(12),